Cargando…

Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results

PURPOSE: This study was undertaken to determine the safety and efficacy of fexapotide triflutate (FT) 2.5 mg and 15 mg for the treatment of Grade Group 1 prostate cancer. METHODS: Prospective randomized transrectal intraprostatic single injection FT 2.5 mg (n = 49), FT 15 mg (n = 48) and control act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shore, Neal, Kaplan, Steven A., Tutrone, Ronald, Levin, Richard, Bailen, James, Hay, Alan, Kalota, Susan, Bidair, Mohamed, Freedman, Sheldon, Goldberg, Kenneth, Snoy, Frederick, Epstein, Jonathan I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716857/ https://www.ncbi.nlm.nih.gov/pubmed/32088746 http://dx.doi.org/10.1007/s00345-020-03127-w

Ejemplares similares

Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement
por: Shore, Neal, et al.
Publicado: (2018)

Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia
por: Shore, Neal, et al.
Publicado: (2019)

Fexapotide Triflutate Induces Selective Prostate Glandular Pharmaco-Ablation in the Rat
por: Averback, Paul, et al.
Publicado: (2019)

Fexapotide triflutate vs oral pharmacotherapy as initial therapy for moderate-to-severe benign prostate hyperplasia patients: a cost-effectiveness analysis
por: Wei, Yifan, et al.
Publicado: (2022)

Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study
por: Rukstalis, Daniel, et al.
Publicado: (2018)

Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer
por: Shore, Neal D., et al.
Publicado: (2023)

Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG)
por: Steinberg, Gary, et al.
Publicado: (2015)

A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer
por: De La Cerda, Jose, et al.
Publicado: (2023)

Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer
por: Saad, Fred, et al.
Publicado: (2023)

A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)
por: Steinberg, Gary D, et al.
Publicado: (2014)

Second Reply to Letter to the Editor re: “Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting”
por: White, Jay, et al.
Publicado: (2019)

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis
por: Tutrone, Ronald, et al.
Publicado: (2023)

The Developmental Phenotype of the Great Toe in Fibrodysplasia Ossificans Progressiva
por: Towler, O. Will, et al.
Publicado: (2020)

Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies
por: Margolis, Erik, et al.
Publicado: (2021)

Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
por: Pignolo, Robert J, et al.
Publicado: (2011)

Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis
por: Kaplan, Frederick S., et al.
Publicado: (2012)

In Vivo Overexpression of IL-13 Receptor α2 Chain Inhibits Tumorigenicity of Human Breast and Pancreatic Tumors in Immunodeficient Mice
por: Kawakami, Koji, et al.
Publicado: (2001)

A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic Hyperplasia
por: Shore, Neal
Publicado: (2015)

Unnecessary Cervical Epidural Injection in An Octogenarian
por: Epstein, Nancy E.
Publicado: (2019)

Grading of prostatic adenocarcinoma: current state and prognostic implications
por: Gordetsky, Jennifer, et al.
Publicado: (2016)

Progressive osseous heteroplasia: diagnosis, treatment, and prognosis
por: Pignolo, Robert J, et al.
Publicado: (2015)

Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
por: Holl, Eda K., et al.
Publicado: (2019)

The Treatment of Sciatica by Means of Saline Injections
por: Hay, Archibald G.
Publicado: (1907)

Reply to Juan Gómez Rivas, Giorgio Gandaglia, and Francesco Montorsi’s Letter to the Editor re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Enzalutamide Monotherapy vs Active Surveillance in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36
por: Shore, Neal D.
Publicado: (2022)

Eltrombopag Modulates Reactive Oxygen Species and Decreases Acute Myeloid Leukemia Cell Survival
por: Kalota, Anna, et al.
Publicado: (2015)

Ethical Implications of Modifying Lethal Injection Protocols
por: Koniaris, Leonidas G, et al.
Publicado: (2008)

Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-046 trial
por: Haas, Naomi B, et al.
Publicado: (2015)

Clinical results of autologous protein solution injection for knee osteoarthritis with severe disease grade is inferior to mild or moderate grade
por: Kuwasawa, Ayano, et al.
Publicado: (2023)

Additional Notes on the Treatment of Sciatica by Means of Saline Injections
por: Hay, Archibald G.
Publicado: (1911)

Major risks and complications of cervical epidural steroid injections: An updated review
por: Epstein, Nancy E.
Publicado: (2018)

Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer
por: Saad, Fred, et al.
Publicado: (2021)

La audiencia investigada /
por: Huertas Bailén, Amparo
Publicado: (2002)

How to prevent endophthalmitis after intravitreal injections
por: Goldberg, Roger A
Publicado: (2015)

Anthrax Lethal Toxin Disrupts Intestinal Barrier Function and Causes Systemic Infections with Enteric Bacteria
por: Sun, Chen, et al.
Publicado: (2012)

New prostate cancer grade group system correlates with prostate cancer death in addition to biochemical recurrence
por: Epstein, Jonathan I
Publicado: (2016)

Neurological complications of lumbar and cervical dural punctures with a focus on epidural injections
por: Epstein, Nancy E.
Publicado: (2017)

The risks of epidural and transforaminal steroid injections in the Spine: Commentary and a comprehensive review of the literature
por: Epstein, Nancy E.
Publicado: (2013)

An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma.
por: Stenning, S. P., et al.
Publicado: (1987)

Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2–10 ng/mL
por: Tutrone, Ronald, et al.
Publicado: (2020)

Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30–80 and 80–150 mL prostates
por: Nguyen, David‐Dan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pdrhkcu6jspclqup0afh1n6dpf